Effects of the Nonapeptide SQ 20881 on Blood Pressure of Rats with Experimental Renovascular Hypertension

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine

• Publication date

  1973-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3181/00379727-143-37348PMID 4709014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme.

  1973cited by this paper
• Chemistry and Biology of Peptides

  1972cited by this paper
• Inhibition of Angiotensin Conversion in Experimental Renovascular Hypertension

  1972cited by this paper
• Inhibition of Angiotensin I-Initiated Hemodynamic Changes in Anesthetized Dogs by a Synthetic Nonapeptide

  1972cited by this paper
• Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic Peptides 1

  1972cited by this paper
• Cleavage of active peptides by a lung enzyme

  1972cited by this paper
• Hypertension of Renal Origin: Evidence for Two Different Mechanisms

  1971cited by this paper
• Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

  1971cited by this paper
• Dual mechanism for experimental hypertension.

  1971cited by this paper
• Inhibition of angiotensin I converting enzyme by venom peptides

  1971cited by this paper
• A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA.

  1965cited by this paper
• STUDIES ON EXPERIMENTAL HYPERTENSION

  1934cited by this paper

• Discovery of novel angiotensin-converting enzyme inhibitory peptides by in silico and in vitro studies

  2025cites this paper
• Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension

  2019cites this paper
• The renin-angiotensin system: new horizons.

  2011cites this paper
• Effects of the nonapeptide SQ 20.881 on the blood pressure of conscious normotensive and chronic hypertensive mice.

  2009cites this paper
• Urinary albumin excretion and the renin–angiotensin system in cardiovascular risk management

  2006cites this paper
• Optimal blockade of the renin angiotensin system in cardiorenal dysfunction

  2006cites this paper
• RENIN SYSTEM IN ONE-KIDNEY HYPERTENSION 721

  2005cites this paper
• New Pharmacological Strategies in Chronic Heart Failure

  2004cites this paper
• Angiotensin I- converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects

  2004cites this paper
• New Pharmacological Strategies in Chronic Heart Failure

  2004cites this paper
• Angiotensin-converting enzyme inhibitors.

  2001cites this paper
• The renin-angiotensin system and the heart: a historical review

  1996cites this paper
• Biochemistry and cell biology of angiotensin-converting enzyme and converting enzyme inhibitors.

  1995cites this paper
• From peptides to peptidases: a chronicle of drug discovery.

  1994cites this paper
• Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.

  1989cites this paper
• Clinical pharmacology of ACE inhibition.

  1989cites this paper
• Angiotensin Reactivity in the Cheek Pouch of the Renovascular Hypertensive Hamster

  1988cites this paper
• Angiotensin-Conversions-Enzym-Hemmung: Direkte und indirekte renale Mechanismen

  1985cites this paper
• [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].

  1985cites this paper
• Discovery, purification and characterization of the angiotensin converting enzyme inhibitor, L-681,176, produced by Streptomyces sp. MA 5143a.

  1984cites this paper
• New approaches to the creation of antihypertensive drugs using inhibitors of angiotensin II formation (review)

  1984cites this paper
• Inhibitors of angiotensin converting enzyme in crude drugs. I.

  1984cites this paper
• [Polypeptides and antagonists].

  1984cites this paper
• Angiotensin-converting enzyme inhibitors: biochemical properties and biological actions.

  1984cites this paper
• Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockade.

  1982cites this paper
• Drugs affecting the renin-angiotensin system.

  1982cites this paper
• Effects of diltiazem on renovascular-hypertensive and on normotensive rats.

  1982cites this paper
• A comparison of the dose-response effects of captopril in anesthetized normotensive and renovascular hypertensive rats.

  1982cites this paper
• Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung.

  1982cites this paper
• Brain Endo‐Oligopeptidase B: A Post‐Proline Cleaving Enzyme that Inactivates Angiotensin I and II

  1982cites this paper
• Development and design of specific inhibitors of angiotensin-converting enzyme.

  1982cites this paper
• Reversal by acetylsalicylic acid of the captopril-induced inhibition of angiotensin converting enzyme in the hindquarters of guinea-pig.

  1982cites this paper
• Effect of converting enzyme and angiotensin II inhibitors in chronic one kidney bipolar ligated hypertension.

  1981cites this paper
• Inhibitors of angiotensin-converting enzyme.

  1980cites this paper
• Captopril and Hypertension

  1980cites this paper
• The fate of circulating biologically active peptides in the lungs.

  1980cites this paper
• Pulmonary angiotensin-converting enzyme and its inhibition: a historical survey.

  1980cites this paper
• Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme.

  1980cites this paper
• [Comparison of blood pressure responses to captopril, an orally active converting enzyme inhibitor, in rats with various forms of experimental hypertension (author's transl)].

  1980cites this paper
• Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence.

  1980cites this paper
• Inhibitors of angiotensin-converting enzyme.

  1980cites this paper
• Screening for Rabbit Brain Neuropeptide‐metabolizing Peptidases. Inhibition of Endopeptidase B by Bradykinin Potentiating Peptide 9a (SQ 20881)

  1980cites this paper
• Acute and chronic effect of captropril in hypertensive patients.

  1980cites this paper
• The Renin-Angiotensin System, Converting Enzyme Inhibition, and Antihypertensive Therapy

  1980cites this paper
• 2 Inhibitiors of Angiotensin-Converting Enzyme

  1980cites this paper
• Design of New Antihypertensive Drugs

  1980cites this paper
• Captopril (Capoten®; SQ 14,225) (d-3-Mercapto-2-methylpropanoyl-l-proline)

  1980cites this paper
• Development of specific inhibitors of angiotensin I converting enzyme (kininase II).

  1979cites this paper
• Symposium on converting enzyme inhibition in hypertension.

  1979cites this paper
• Angiotensin and Sodium Balance: Their Role in Chronic Two‐Kidney Goldblatt Hypertension

  1979cites this paper
• Fate of bradykinin-potentiating peptide 9a after intravenous injection.

  1979cites this paper
• Role of endogenous prostaglandins on the conversion of angiotensin I to angiotensin II in the pulmonary circulation.

  1979cites this paper
• The Role Angiotensin of in the Control of Blood Pressure During Sodium Depletion

  1979cites this paper
• Role of aldosterone in experimental hypertension.

  1979cites this paper
• Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.

  1978cites this paper
• Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

  1978cites this paper
• Reversal of renovascular hypertension by antibodies specific for angiotensin-converting enzyme.

  1978cites this paper
• Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.

  1978cites this paper
• Physiologic, biochemical, and immunologic aspects of angiotensin-converting enzyme.

  1978cites this paper
• Chapter 9. Inhibitors of the Renin-Angiotensin System

  1978cites this paper
• Design of new antihypertensive drugs: potent and specific inhibitors of angiotensin-converting enzyme.

  1978cites this paper
• SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme.

  1978cites this paper
• Converting enzyme, angiotensin II and hypertensive disease.

  1978cites this paper
• Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs.

  1978cites this paper
• Existence of a new vasoactive factor in experimental hypertension.

  1978cites this paper
• Saralasin and SQ 20881 : their effects on central nervous system norepinephrine.

  1978cites this paper
• Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

  1977cites this paper
• [The tonin-angiotensin II system].

  1977cites this paper
• INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM IN RATS WITH MALIGNANT AND SPONTANEOUS HYPERTENSION: COMPARATIVE ANTIHYPERTENSIVE EFFECTS OF CENTRAL VS. PERIPHERAL ADMINISTRATION

  1977cites this paper
• Goldblatt hypertension in a solitary kidney.

  1977cites this paper
• Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids.

  1977cites this paper
• The angiotensin I converting enzyme.

  1977cites this paper
• Potentiation by crude kallikrein of the myotropic effect of angiotensin I in the isolated rabbit aortic strip

  1977cites this paper
• The effects of angiotensin I and angiotensin II on the isolated tracheal muscle of the cat *

  1976cites this paper
• Central antihypertensive effects of inhibitors of the renin-angiotensin system in rats.

  1976cites this paper
• The biochemistry of the renin-angiotensin system and its role in hypertension.

  1976cites this paper
• Angiotensin-converting enzyme and the regulation of vasoactive peptides.

  1976cites this paper
• Peripheral circulation in arterial hypertension.

  1976cites this paper
• Conversion of angiotensin I to angiotensin II.

  1976cites this paper
• Chronic One-Kidney Hypertension in Rabbits

  1975cites this paper
• Chronic One‐Kidney Hypertension in Rabbits: II. Evidence for a New Factor

  1975cites this paper
• Angiotensin I converting enzyme.

  1975influential citation
• BRADYKININASE AND CONVERTING ENZYME IN LUNG

  1975cites this paper
• Chronic one-kidney hypertension in rabbits. I. Treatment with kidney extracts.

  1975cites this paper
• The renin-angiotensin system in rats made hypertensive by ligation of the kidney poles (38584).

  1975cites this paper
• Effect of blockade of angiotensin-I converting enzyme on the blood pressure of renal hypertensive rabbits.

  1974cites this paper
• Sar1-Ala8 angiotensin II blocks renin-angiotensin but not beta-adrenergic dipsogenesis.

  1974cites this paper
• Intestinal vasoconstriction following diuretic-induced volume depletion: role of angiotensin and vasopressin.

  1974cites this paper